Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mrudula Pullambhatla

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2011
2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancerYing Chen, Mrudula Pullambhatla, Catherine A Foss, et al.
Journal of Medicinal Chemistry|February 19, 2014
⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancerSangeeta Ray Banerjee, Mrudula Pullambhatla, Catherine A Foss, et al.
Journal of Medicinal Chemistry|June 24, 2010
68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancerSangeeta Ray Banerjee, Mrudula Pullambhatla, Youngjoo Byun, et al.
Bioconjugate Chemistry|November 20, 2012
Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigenYing Chen, Mrudula Pullambhatla, Sangeeta R Banerjee, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studiesHaofan Wang, Youngjoo Byun, Cyril Barinka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
Low-Level Endogenous PSMA Expression in Nonprostatic Tumor Xenografts Is Sufficient for In Vivo Tumor Targeting and ImagingSridhar Nimmagadda, Mrudula Pullambhatla, Ying Chen, et al.
Nuclear Medicine and Biology|July 21, 2014
Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)Lauren E Woodard, Ravindra A De Silva, Babak Behnam Azad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2015
Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane AntigenAna P Kiess, Il Minn, Ying Chen, et al.
The Journal of Molecular Diagnostics : JMD|December 12, 2022
Assessments of Somatic Variant Classification Using the Association for Molecular Pathology/American Society of Clinical Oncology/College of American Pathologists Guidelines: A Report from the Association for Molecular PathologyMarilyn M Li, Catherine E Cottrell, Mrudula Pullambhatla, et al.
Journal of Photochemistry and Photobiology. B, Biology|January 8, 2017
A PSMA-targeted theranostic agent for photodynamic therapyYing Chen, Samit Chatterjee, Ala Lisok, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2011
2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancerYing Chen, Mrudula Pullambhatla, Catherine A Foss, et al.
Journal of Medicinal Chemistry|February 19, 2014
⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancerSangeeta Ray Banerjee, Mrudula Pullambhatla, Catherine A Foss, et al.
Journal of Medicinal Chemistry|June 24, 2010
68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancerSangeeta Ray Banerjee, Mrudula Pullambhatla, Youngjoo Byun, et al.
Bioconjugate Chemistry|November 20, 2012
Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigenYing Chen, Mrudula Pullambhatla, Sangeeta R Banerjee, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studiesHaofan Wang, Youngjoo Byun, Cyril Barinka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
Low-Level Endogenous PSMA Expression in Nonprostatic Tumor Xenografts Is Sufficient for In Vivo Tumor Targeting and ImagingSridhar Nimmagadda, Mrudula Pullambhatla, Ying Chen, et al.
Nuclear Medicine and Biology|July 21, 2014
Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)Lauren E Woodard, Ravindra A De Silva, Babak Behnam Azad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2015
Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane AntigenAna P Kiess, Il Minn, Ying Chen, et al.
The Journal of Molecular Diagnostics : JMD|December 12, 2022
Assessments of Somatic Variant Classification Using the Association for Molecular Pathology/American Society of Clinical Oncology/College of American Pathologists Guidelines: A Report from the Association for Molecular PathologyMarilyn M Li, Catherine E Cottrell, Mrudula Pullambhatla, et al.
Journal of Photochemistry and Photobiology. B, Biology|January 8, 2017
A PSMA-targeted theranostic agent for photodynamic therapyYing Chen, Samit Chatterjee, Ala Lisok, et al.
Pageof 4